Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombosis × salicylhydroxamic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Myocardial Reperfusion Injury 2 Cardiotoxicity 2 Vomiting 1 Uveal Melanoma 1 Thrombosis 1 Substance Withdrawal Syndrome 1 Retinal Diseases 1 Reperfusion Injury 1 Pain, Postoperative 1 Opioid-Related Disorders 1 Nausea 1 Melanoma 1 Macular Degeneration 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Choroid Diseases 1 Breast Neoplasms 1

Interventions

apixaban 6 Heparin, Low-Molecular-Weight 4 Enoxaparin 4 Dalteparin 4 Rivaroxaban 3 Blood Specimen Collection 3 Warfarin 2 Injections 2 Aspirin 2 Anticoagulants 2 salicylhydroxamic acid 1 palbociclib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 enoxaparin sodium 1 edoxaban 1 bemiparin 1 X-Rays 1 Ultrasonography 1 Tinzaparin 1 Technetium Tc 99m Sulfur Colloid 1 Standard of Care 1 Simvastatin 1 Saline Solution 1 Radiotherapy, Conformal 1 Physical Therapy Modalities 1 Photons 1 Phlebotomy 1 Paclitaxel 1 Observation 1 Musculoskeletal Manipulations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548377 2018-03-05

RIPC-HNC

Aarhus University Hospital Skejby

Phase NA Completed

Head and Neck Neoplasms, Thrombosis, Reperfusion Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡